Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

High-risk Human Papillomavirus Genotypes in Cervical Lesions and Vaccination Challenges in China

  • Xu, Qiu-Xiang (Department of Obstetrics and Gynecology, Beijing Chaoyang Hospital, Affiliated to Capital Medical University) ;
  • Zhang, Zhen-Yu (Department of Obstetrics and Gynecology, Beijing Chaoyang Hospital, Affiliated to Capital Medical University)
  • Published : 2015.04.03
Download PDF
⟨ Previous Next ⟩

Abstract

Cervical cancer, mostly progressing from cervical intraepithelial neoplasia, is a major cause of morbidity and mortality in Chinese women. This is largely due to high prevalence of high-risk human papillomaviruses (hr-HPVs) in the population. The prevalence of hr-HPV DNA in women and in cervical lesions women ranged from 9.9% to 17.% and from 50.5% to 70.9% in different regions of China, respectively. The most common genotypes somewhat differ between regions throughout the country and from those in many other countries. This may be a challenge to cervical cancer screening and prevention in China. Combined detection of particular HPV genotypes should be recommended in all geographical regions in China and greater attention must be paid to specific hr-HPV types during cervical cancer screening and follow-up of cervical lesions. Besides, vaccination for prevention of cervical cancer by particular HPV genotypes, has not been introduced to China so far. Updated knowledge on prevalent HPV genotypes should be provided to public health organizations to help with the development of more effective HPV vaccines, which can protect Chinese women against HPV types prevalent in local China and thus have a substantial impact on the cervical cancer burden.

Keywords

References

  1. Agosti JM, Goldie SJ (2007). Introducing HPV vaccine in developing countries-key challenges and issues. N Engl J Med, 356, 1908-10. https://doi.org/10.1056/NEJMp078053
  2. Burger RA, Monk BJ, Kurosaki T, et al (1996). Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer. J Natl Cancer Inst, 88, 1361-8. https://doi.org/10.1093/jnci/88.19.1361
  3. Chan PKS, Ho WCS, Chan MCW, et al (2014). Meta-analysis on prevalence and attribution of human papillomavirus types 52 and 58 in cervical neoplasia worldwide. PLoS One, 9, 107573. https://doi.org/10.1371/journal.pone.0107573
  4. Chen ZF, Meng W, Du R, et al (2013). Genotype distribution and the relative risk factors for human papillomavirus in Urumqi, China. Exp Ther Med, 6, 85-90.
  5. Chou P (1991). Review on risk factors of cervical cancer. Zhonghua Yi Xue Za Zhi, 48, 81-8.
  6. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S (2003). Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer, 88, 63-73. https://doi.org/10.1038/sj.bjc.6600688
  7. Desruisseau AJ, Schmidt-Grimminger D, Welty E (2009). Epidemiology of HPV in HIV-positive and HIV-negative fertile women in Cameroon, West Africa. Infect Dis Obstet Gynecol, 2009, 810596.
  8. Ding X, Liu Z, Su J, et al (2014). Human papillomavirus type-specific prevalence in women referred for colposcopic examination in Beijing. J Med Virol, 86, 1937-43. https://doi.org/10.1002/jmv.24044
  9. Drolet M, Laprise JF, Boily MC, et al (2014). Potential cost-effectiveness of the nonavalent human papillomavirus (HPV) vaccine. Int J Cancer, 134, 2264-8. https://doi.org/10.1002/ijc.28541
  10. Hildesheim A, Hadjimichael O, Schwartz PE, et al (1999). Risk factors for rapid-onset cervical cancer. Am J Obstet Gynecol, 180, 571-7. https://doi.org/10.1016/S0002-9378(99)70256-5
  11. Hou R, Xu CY, Zhang SW, Wu MH, Zhang WY (2012). Distribution of human papillomavirus genotype and cervical neoplasia among women with abnormal cytology in Beijing, China. Int J Gynaecol Obstet, 119, 257-61. https://doi.org/10.1016/j.ijgo.2012.07.011
  12. International Agency for Research on Cancer (2014). GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012. Available: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx.
  13. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
  14. Jing LP, Zhong XM, Huang WH, et al (2014). HPV genotypes and associated cervical cytological abnormalities in women from the pearl river delta region of guangdong province, China: a cross-sectional study. BMC Infect Dis, 14, 388-96. https://doi.org/10.1186/1471-2334-14-388
  15. Kawana K, Yasugi T, Taketani Y (2009). Human papillomavirus vaccines: current issues and future. Indian J Med Res, 130, 341-7.
  16. Kim K, Zang R, Choi SC, et al (2009). Current status of gynecological cancer in China. J Gynecol Oncol, 20, 72-7. https://doi.org/10.3802/jgo.2009.20.2.72
  17. Kj.r SK, Breugelmans G, Munk C, et al (2008). Population-based prevalence, type-and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark. Int J Cancer, 123, 1864-70. https://doi.org/10.1002/ijc.23712
  18. Li CD, Wu MH, Wang JD, et al (2010). A population-based study on the risks of cervical lesion and human papillomavirus infection among women in beijing, people's republic of China. Cancer Epidemiol Biomarkers Prev, 19, 2655-64. https://doi.org/10.1158/1055-9965.EPI-10-0212
  19. Li JK, Zhang D, Zhang Y, et al (2011). Prevalence and genotype distribution of human papillomavirus in women with cervical cancer or high-grade precancerous lesions in Chengdu, western China. Int J Gynecol Obstet, 112, 131-4. https://doi.org/10.1016/j.ijgo.2010.08.010
  20. Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM (2011). Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication. Int J Cancer, 128, 927-35. https://doi.org/10.1002/ijc.25396
  21. Li Y, Wang YP, Jia CW, et al (2008). Detection of human papillomavirus genotypes with liquid bead microarray in cervical lesions of northern Chinese patients. Cancer Genet Cytogenet, 182, 12-7. https://doi.org/10.1016/j.cancergencyto.2007.12.007
  22. Liu X, Zhang SL, Ruan Q, et al (2010). Prevalence and type distribution of human papillomavirus in women with cervical lesions in liaoning province, China. Int J Gynecol Cancer, 20, 147-53. https://doi.org/10.1111/IGC.0b013e3181c20860
  23. Lo KWK, Wong YF, Chan MKM, et al (2002). Prevalence of human papillomavirus in cervical cancer: a multicenter study in China. Int J Cancer, 100, 327-31. https://doi.org/10.1002/ijc.10506
  24. Mai RQ, Huang B, Shen L, et al (2014). Genotype distribution of human papillomavirus in women with abnormal cervical cytology in an esophageal carcinoma high incidence area of China. Asian Pac J Cancer Prev, 15, 4945-50. https://doi.org/10.7314/APJCP.2014.15.12.4945
  25. Marsh K, Chapman R, Baggaley RF, Largeronc N, Bresse X (2014). Mind the gaps: What's missing from current economic evaluations of universal HPV vaccination? Vaccine, 32, 3732-9. https://doi.org/10.1016/j.vaccine.2014.05.007
  26. Moore EE, Wark JD, Hopper JL, et al (2012). Study Group: The roles of genetic and environmental factors on risk of cervical cancer: a review of classical twin studies. Twin Res Hum Genet, 15, 79-86. https://doi.org/10.1375/twin.15.1.79
  27. Onuki M, Matsumoto K, Satoh T, et al (2009). Human papillomavirus infections among Japanese women: age-related prevalence and type-specific risk for cervical cancer. Cancer Sci, 100, 1312-6. https://doi.org/10.1111/j.1349-7006.2009.01161.x
  28. Roura E, Castellsague X, Pawlita M, et al (2014). Smoking as a major risk factor for cervical cancer and pre-cancer: results from the EPIC cohort. Int J Cancer, 135, 453-66. https://doi.org/10.1002/ijc.28666
  29. Sahasrabuddhe VV, Mwanahamuntu MH, Vermund SH, et al (2007). Prevalence and distribution of HPV genotypes among HIV-infected women in Zambia. Br J Cancer, 96, 1480-3.
  30. Sanjose SD, Qunit GVW, Alemany L, et al (2010). Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol, 11, 1048-56. https://doi.org/10.1016/S1470-2045(10)70230-8
  31. Schiffman M, Castle PE, Jeronimo J, et al (2007). Human papillomavirus and cervical cancer. Lancet, 370, 890-907. https://doi.org/10.1016/S0140-6736(07)61416-0
  32. Schwartz SM, Daling JR, Shera KA, et al (2001). Human papillomavirus and prognosis of invasive cervical cancer: a population-based study. J Clin Oncol, 19, 1906-15.
  33. Shepherd JP, Frampton GK, Harris P (2014). Interventions for encouraging sexual behaviours intended to prevent cervical cancer. Cochrane Database Syst Rev, 4, 1035.
  34. Sjoeborg KD, Trope A, Lie AK, et al (2010). HPV genotype distribution according to severity of cervical neoplasia. Gynecol Oncol, 118, 29-34. https://doi.org/10.1016/j.ygyno.2010.03.007
  35. Smith JS, Lindsay L, Hoots B, et al (2007). Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer, 121, 621-32. https://doi.org/10.1002/ijc.22527
  36. Walboomers JM, Jacobs MV, Manos MM, et al (2012). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol, 189, 12-9.
  37. Wang L, Dai SZ, Chu HJ, Cui HF, Xu XY (2013). Intergration sites and genotype distributions of human papillomavirus in cervical intraepithelial neoplasia. Asian Pac J Cancer Prev, 14, 3837-41. https://doi.org/10.7314/APJCP.2013.14.6.3837
  38. Wright TC, Stoler MH, Behrens CM, et al (2012). The ATHENA human papillomavirus study: design, methods, and baseline results. Am J Obstet Gynecol, 206, 46.
  39. Wu EQ, Yu XH, Zha X, et al (2009). Distribution of human papillomavirus genotypes in archival cervical lesions in eastern inner mongolian autonomous region, China. Int J Gynecol Cancer, 19, 919-23. https://doi.org/10.1111/IGC.0b013e3181a58fef
  40. Ye J, Cheng XD, Chen XJ, et al (2010). Prevalence and risk profile of cervical human papillomavirus infection in Zhejiang Province, southeast China: a population-based study. Virol J, 7, 66-76. https://doi.org/10.1186/1743-422X-7-66
  41. Zhang R, Velicer C, Chen W, et al (2013). Human papillomavirus genotype distribution in cervical intraepithelial neoplasia grade 1 or worse among 4215 Chinese women in a population-based study. Cancer Epidemiol, 37, 939-45. https://doi.org/10.1016/j.canep.2013.10.005
  42. Zhang WY, Xue YZ, Chen M, Han L, Luo M (2008). Prevalence of high-risk human papillomavirus infection in different cervical lesion among organized health-examination women in Shanghai, China. Chin Med J (, 121, 1578-82.
  43. Zhao FH, Lewkowitz AK, Hu SY, et al (2012). Prevalence of human papillomavirus and cervical intraepithelial neoplasia in China: a pooled analysis of 17 population-based studies. Int J Cancer, 131, 2929-38. https://doi.org/10.1002/ijc.27571
  44. Zhao R, Zhang WY, Wu MH, et al (2009). Human papillomavirus infection in beijing, people's republic of China: a population-based study. Br J Cancer, 101, 1635-40. https://doi.org/10.1038/sj.bjc.6605351

Cited by

  1. Genotype distribution and prevalence of human papillomavirus among women with cervical cytological abnormalities in Xinjiang, China pp.2164-554X, 2019, https://doi.org/10.1080/21645515.2019.1578598